Hostname: page-component-cb9f654ff-rkzlw Total loading time: 0 Render date: 2025-08-24T12:06:24.028Z Has data issue: false hasContentIssue false
  • English
  • Français

Parotid metastasis from carcinoma urinary bladder treated with CyberKnife-based stereotactic body radiotherapy: case report and review of literature

Published online by Cambridge University Press:  30 October 2014

Tejinder Kataria ,
Shyam S Bisht ,
Deepak Gupta ,
Ashu Abhishek ,
Govardhan Hb ,
Shikha Goyal ,
Trinanjan Basu  and
Vikash Kumar
Tejinder Kataria
Affiliation:
Division of Radiation Oncology, Medanta cancer institute, Medanta The Medicity, Gurgaon, India
Shyam S Bisht
Affiliation:
Division of Radiation Oncology, Medanta cancer institute, Medanta The Medicity, Gurgaon, India
Deepak Gupta*
Affiliation:
Division of Radiation Oncology, Medanta cancer institute, Medanta The Medicity, Gurgaon, India
Ashu Abhishek
Affiliation:
Division of Radiation Oncology, Medanta cancer institute, Medanta The Medicity, Gurgaon, India
Govardhan Hb
Affiliation:
Division of Radiation Oncology, Medanta cancer institute, Medanta The Medicity, Gurgaon, India
Shikha Goyal
Affiliation:
Division of Radiation Oncology, Medanta cancer institute, Medanta The Medicity, Gurgaon, India
Trinanjan Basu
Affiliation:
Division of Radiation Oncology, Medanta cancer institute, Medanta The Medicity, Gurgaon, India
Vikash Kumar
Affiliation:
Division of Radiation Oncology, Medanta cancer institute, Medanta The Medicity, Gurgaon, India
*
Correspondence to: Dr Deepak Gupta, Division of Radiation Oncology,Medanta cancer institute, Medanta The Medicity, Gurgaon, India. E-mail: deepakonco@gmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Metastases to the parotid region are relatively infrequent and originate primarily from head and neck cancer. Metastases of an infraclavicular origin are uncommon. Moreover, metastasis from the carcinoma of urinary bladder (CUB) to any part of the head and neck, including parotid gland, is rare. Surgery and chemotherapy are usually offered. We report a case of solitary parotid metastasis from CUB, who was successfully treated with stereotactic body radiotherapy (SBRT) using CyberKnife. SBRT is a safe alternative in cases unwilling/unfit for surgery.

Keywords

carcinoma urinary bladderCyberKnifeparotid metastasisstereotactic body radiotherapy

Information

Type
Case Study
Information
Journal of Radiotherapy in Practice , Volume 14 , Issue 1 , March 2015 , pp. 88 - 91
Check for updates
Copyright
© Cambridge University Press 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1.Vara, A, Madrigal, B, Perez del Rio, M Jet al. Parotid metastasis from renal clear cell adenocarcinoma. An unusual site of metastasis. Uro Int 1998; 61: 196–198.Google Scholar
2.Pisani, P, Angeli, G, Krangli, M, Pia, F. Renal carcinoma metastasis to the parotid gland. J Laryngol Otol 1990; 104: 352–354.Google Scholar
3.Hessan, H, Strauss, M, Sharkey, F E. Urogenital tract carcinoma metastatic to the head and neck. Laryngoscope 1986; 96: 1352–1356.Google Scholar
4.Conley, J, Arena, S. Parotid gland as a focus of metastasis. Arch Surg 1963; 87: 757–764.Google Scholar
5.Hirshberg, A, Buchner, A. Metastatic tumours to the oral region. An overview. Oral Oncol Eur J Cancer 1995; 31B: 355–360.Google Scholar
6.Shimoyama, T, Horie, N, Yamada, T, Ide, F. Parotid lymph node metastasis from adenocarcinoma of the urachus. Dentomaxillofac Radiol 2000; 29: 185–188.Google Scholar
7.Horii, A, Yoshida, J, Honjo, Y, Mitani, K, Takashima, S, Kubo, T. Preoperative assessment of metastatic parotid tumors. Auris Nasus Larynx 1998; 25 (3): 277–283.CrossRefGoogle ScholarPubMed
8.Li, Y, Yang, Z Q, Ye, H, Qi, L, Hu, J W. Application of (18)F-FDG PET/CT imaging in diagnosing bladder tumor metastasis lesions. J Huazhong Univ Sci Technolog Med Sci 2013; 33 (2): 234–237.CrossRefGoogle ScholarPubMed
9.Jecker, P, Hartwein, J. Metastasis to the parotid gland: is a radical surgical approach justified? Am J Otolaryngol 1996; 17 (2): 102–105.Google Scholar
10.Bron, L P, Traynor, S J, McNeil, E B, O’Brien, C J. Primary and metastatic cancer of the parotid: comparison of clinical behavior in 232 cases. Laryngoscope 2003; 113 (6): 1070–1075.CrossRefGoogle ScholarPubMed
11.Krengli, M, Pisani, P, Pia, F. Exclusive radiotherapy of parotid metastases. Results in 14 cases. Radiol Med 1993; 86 (5): 684–686.Google ScholarPubMed
12.Weichselbaum, R R, Hellman, S. Oligometastases revisted. Nat Rev Clin Oncol 2011; 8: 378–382.Google Scholar
13.Niibe, Y, Hayakawa, K. Oligometastases and oligo-recurrence. Jpn J Clin Oncol 2010; 40: 107–111.Google Scholar
14.Karam, S D, Snider, J W, Wang, H, Wooster, M. Survival outcomes of patients treated with hypofractionated stereotactic body radiation therapy for parotid gland tumors: a retrospective analysis. Front Oncol 2012; 2: 55.Google Scholar
15.Karam, S D, Snider, J W, Wang, Het al. Reirradiation of recurrent salivary gland malignancies with fractionated stereotactic body radiation therapy. J Radiat Oncol 2012; 1 (2): 147–153.Google Scholar